Epigenetics in CKD & CVD: A potential breakthrough therapy?
Meeting report with video, highlights and slides of PACE-CME symposium held during ERA-EDTA 2018 in Copenhagen on the potential role of epigenetics in patients with CKD, CVD and diabetes
Episodes 1-3 of 3
- Epigenetics in CKD & CVD: A potential breakthrough therapy?Epigenetics in CKD: Rationale for BET inhibition, an emerging therapeutic mechanism in renal disease and CVD
- Epigenetics in CKD & CVD: A potential breakthrough therapy?Cardiovascular disease in diabetes and CKD & residual risk: The promise of epigenetics
Prof. Erik Stroes, MD
- Epigenetics in CKD & CVD: A potential breakthrough therapy?A clinical view on BET inhibition in CKD & CVD: Understanding recent data and future perspectives
Kamyar Kalantar-Zadeh, MD
